6133 — Vital Innovations Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$134.30m
- HK$144.60m
- CNY835.61m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 816 | 881 | 673 | 1,092 | 836 |
Cost of Revenue | |||||
Gross Profit | 7.68 | -79.6 | -0.486 | 4.7 | 3.01 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 820 | 978 | 693 | 1,109 | 855 |
Operating Profit | -4.54 | -96.9 | -20 | -16.7 | -19.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.57 | -97.6 | -20.6 | -17.6 | -20.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.57 | -97.6 | -20.6 | -17.6 | -20.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -5.57 | -97.6 | -20.5 | -17.5 | -20.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.57 | -97.6 | -20.5 | -17.5 | -20.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.116 | -0.024 | -0.021 | -0.025 |
Special Dividends per Share |